Jared Gollob, Chief Medical Officer: Kymera Therapeutics KYMR Planned sale · Filed 03/02

Trade details

Type: Planned sale notice
Stock: Kymera Therapeutics KYMR
Person: Jared GollobChief Medical Officer
Planned sale date: 26/03/02
Filed: 26/03/02

More to sell after $3.3M in 3 months

Kymera Therapeutics trades, last 26 weeks

What else happened in Kymera Therapeutics around then

Filed or reported within 30 days of the trade day · 01/31~04/01

Jared Gollob's recent trades

Jared GollobChief Medical Officer
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$273.3K
3,048 sh
$273.3K
Filed 03/04
Traded 03/02
Jared GollobChief Medical Officer
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$214.2K
2,519 sh
$214.2K
Filed 03/04
Traded 03/04
Jared GollobChief Medical Officer
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$132.5K
1,510 sh
$132.5K
Filed 03/04
Traded 03/02
Jared GollobChief Medical Officer
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$123.3K
1,437 sh
$123.3K
Filed 03/04
Traded 03/04
Jared GollobChief Medical Officer
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$93.4K
1,055 sh
$93.4K
Filed 03/04
Traded 03/02